Amphastar Pharmaceuticals Inc (AMPH)
44.55
+0.46
(+1.04%)
USD |
NASDAQ |
Nov 21, 16:00
45.21
+0.66
(+1.48%)
Pre-Market: 08:31
Amphastar Pharmaceuticals Profit Margin (Quarterly): 21.14% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.14% |
| June 30, 2024 | 20.81% |
| March 31, 2024 | 25.13% |
| December 31, 2023 | 20.31% |
| September 30, 2023 | 27.26% |
| June 30, 2023 | 17.93% |
| March 31, 2023 | 18.59% |
| December 31, 2022 | 25.12% |
| September 30, 2022 | 13.21% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 20.15% |
| December 31, 2021 | 16.35% |
| September 30, 2021 | 26.34% |
| June 30, 2021 | 7.64% |
| March 31, 2021 | 4.89% |
| December 31, 2020 | -6.54% |
| September 30, 2020 | 4.70% |
| June 30, 2020 | -0.22% |
| March 31, 2020 | 4.66% |
| December 31, 2019 | -1.23% |
| September 30, 2019 | 1.63% |
| June 30, 2019 | 60.45% |
| March 31, 2019 | 1.09% |
| December 31, 2018 | 2.08% |
| Date | Value |
|---|---|
| September 30, 2018 | 3.16% |
| June 30, 2018 | -4.02% |
| March 31, 2018 | -12.23% |
| December 31, 2017 | 1.30% |
| September 30, 2017 | 0.17% |
| June 30, 2017 | 3.03% |
| March 31, 2017 | 1.58% |
| December 31, 2016 | -5.44% |
| September 30, 2016 | 6.06% |
| June 30, 2016 | 10.13% |
| March 31, 2016 | 4.19% |
| December 31, 2015 | 9.79% |
| September 30, 2015 | -4.71% |
| June 30, 2015 | -12.34% |
| March 31, 2015 | -1.17% |
| December 31, 2014 | -4.51% |
| September 30, 2014 | -9.01% |
| June 30, 2014 | -2.41% |
| March 31, 2014 | -3.53% |
| December 31, 2013 | 3.33% |
| September 30, 2013 | -0.27% |
| June 30, 2013 | 12.49% |
| March 31, 2013 | 4.50% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.54%
Minimum
Dec 2020
27.26%
Maximum
Sep 2023
14.01%
Average
17.14%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| BridgeBio Pharma Inc | -5.93K% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.56% |
| Return on Assets | 10.28% |
| Return on Invested Capital | 12.41% |
| Gross Profit Margin (Quarterly) | 53.31% |
| Operating Margin (Quarterly) | 29.83% |
| Return on Net Operating Assets | 13.44% |